ArticleNPJ breast cancer2026

Machine learning-based identification of high-risk triple-negative breast cancer patients despite pathological complete response after neoadjuvant chemotherapy.

Koen Kwakkenbos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.